On January 18, 2022, Vyant Bio, Inc. (the “Company”) and Mr. Ping Yeh, MS, MBA, PMP, PgMP, agreed that Mr. Yeh would step down as Chief Innovation Officer of the Company, effective as of February 11, 2022, and that his employment agreement would be deemed terminated as of that date by the Company without cause for purposes of determining severance thereunder. Such agreement was not the result of any disagreement Mr. Yeh had with the Company on any matters relating to the Company's operations, policies or practices. Mr. Yeh will remain a member of the Board of Directors of the Company.